Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Interest Expenses (2016 - 2025)

Jaguar Health (JAGX) has disclosed Interest Expenses for 11 consecutive years, with $6000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses rose 103.7% to $6000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$175000.0, a 129.71% decrease, with the full-year FY2024 number at $231000.0, down 96.38% from a year prior.
  • Interest Expenses was $6000.0 for Q3 2025 at Jaguar Health, up from -$15000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $4.2 million in Q1 2022 to a low of -$162000.0 in Q3 2024.
  • A 5-year average of $1.4 million and a median of $611000.0 in 2024 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: skyrocketed 209600.0% in 2022, then plummeted 144.35% in 2024.
  • Jaguar Health's Interest Expenses stood at $2.4 million in 2021, then grew by 8.26% to $2.6 million in 2022, then plummeted by 90.58% to $248000.0 in 2023, then crashed by 144.35% to -$110000.0 in 2024, then skyrocketed by 105.45% to $6000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Interest Expenses are $6000.0 (Q3 2025), -$15000.0 (Q2 2025), and -$56000.0 (Q1 2025).